EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Epigenetic Modeling of Jumping Translocations of 1q Heterochromatin in Acute Myeloid Leukemia After 5'‐Azacytidine Treatment

Anair Graciela Lema Fernandez iD, Carlotta Nardelli iD, Valentina Pierini, Barbara Crescenzi, Fabrizia Pellanera, Caterina Matteucci, Maria Crocioni, Silvia Arniani, Valeria Di Battista, Martina Quintini, Giada Mondanelli, Ciriana Orabona iD und 2 weitere

Genes, Chromosomes and Cancer · 2024

DOI: 10.1002/gcc.70013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, Chromosomes and Cancer, 2024. Verfasst von Anair Graciela Lema Fernandez und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, Hematology and Bone Marrow Transplantation Unit, University of Perugia, Perugia, Italy. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Translocation, Genetic, Epigenesis, Genetic, Heterochromatin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Associazione Italiana per la Ricerca sul Cancro, COST (European Cooperation in Science and Technology), Consorzio Interuniversitario per le Biotecnologie (C.I.B.).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Jumping translocations (JT) are rare cytogenetic abnormalities associated with progression in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Typically, a tri–tetra‐somic 1q chromosome is translocated to two or more recipient chromosomes. In multiple myeloma JT were shown to originate after DNA demethylation and decondensation. Using epigenomics, we investigated sequential samples in an SRSF2 ‐mutated MDS and AML cohort with normal karyotype at diagnosis and 1qJT at disease evolution after 5′‐azacytidine (AZA). 1qJT breakpoints fell within repetitive DNA at both 1q12 and the translocation partners, namely acrocentrics n. 14, 15, 21, and 22, chromosome 16, and chromosome Y. The global methylome at diagnosis showed hypermethylation at 61% of the differentially methylated regions (DMRs), followed by hypomethylation at 80% of DMRs under AZA, mostly affecting pathways related to immune system, chromatin organization, chromosome condensation, telomere maintenance, rRNA, and DNA repair. At disease evolution, a shift toward hypermethylation, intronic enhancers enrichment and epigenetic involvement of the PI3K/AKT and MAPK signaling emerged. In particular, AKT1 phosphorylation behaved as a hallmark of the progression. Overall, we provided new insights on the characterization of 1qJT in SRSF2 ‐mutated myeloid neoplasms and first showed that epigenetics is a powerful tool to investigate the molecular landscape of repetitive DNA rearrangements.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteTranslocation, GeneticEpigenesis, GeneticHeterochromatinChromosomes, Human, Pair 1AzacitidineDNA MethylationHumansFemaleMaleAgedMiddle AgedMyelodysplastic Syndromes

Stichwörter der Autor:innen

5‐azacytidineDNA methylationMDS/AMLjumping 1q

Substanzen

HeterochromatinAzacitidine

Autor:innen und Institutionen

  • Department of Medicine and Surgery, Hematology and Bone Marrow Transplantation Unit, University of Perugia, Perugia, Italy.
  • Department of Medicine and Surgery, Section of Pharmacology, University of Perugia, Perugia, Italy.
  • Department of Chemistry, Biology and Biotechnology, University of Perugia, Perugia, Italy.

ORCID-Profile: Anair Graciela Lema Fernandez, Carlotta Nardelli, Ciriana Orabona

Förderung

  • Associazione Italiana per la Ricerca sul Cancro
  • COST (European Cooperation in Science and Technology)
  • Consorzio Interuniversitario per le Biotecnologie (C.I.B.)
  • PNC, LSH-TA
  • Fondazione AIRC per la ricerca sul cancro ETS
  • European Cooperation in Science and Technology
  • Consorzio Interuniversitario Biotecnologie

Zitieren

APA

Lema Fernandez, A. G., Nardelli, C., Pierini, V., Crescenzi, B., Pellanera, F., Matteucci, C., Crocioni, M., Arniani, S., Di Battista, V., Quintini, M., Mondanelli, G., Orabona, C., Gorello, P., & Mecucci, C. (2024). Epigenetic Modeling of Jumping Translocations of 1q Heterochromatin in Acute Myeloid Leukemia After 5'‐Azacytidine Treatment. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.70013

Vancouver

Lema Fernandez AG, Nardelli C, Pierini V, Crescenzi B, Pellanera F, Matteucci C, et al. Epigenetic Modeling of Jumping Translocations of 1q Heterochromatin in Acute Myeloid Leukemia After 5'‐Azacytidine Treatment. Genes, Chromosomes and Cancer. 2024. doi:10.1002/gcc.70013

BibTeX
@article{LemaFernandez2024,
  author = {Lema Fernandez, Anair Graciela and Nardelli, Carlotta and Pierini, Valentina and Crescenzi, Barbara and Pellanera, Fabrizia and Matteucci, Caterina and Crocioni, Maria and Arniani, Silvia and Di Battista, Valeria and Quintini, Martina and Mondanelli, Giada and Orabona, Ciriana and Gorello, Paolo and Mecucci, Cristina},
  title = {Epigenetic Modeling of Jumping Translocations of 1q Heterochromatin in Acute Myeloid Leukemia After 5'‐Azacytidine Treatment},
  journal = {Genes, Chromosomes and Cancer},
  year = {2024},
  doi = {10.1002/gcc.70013}
}
Kostenlos starten →